Candida albicans antigen ELISA Kit (DEIA809)

Regulatory status: For research use only, not for use in diagnostic procedures.

Write a review

Serum, plasma
Intended Use
Candida albicans antigen ELISA Kit is a quantitative and qualitative immunoassay for the detection of Candida antigen in human serum or plasma. The assay is recommended for the detection of systemic candidosis.
This kit should be stored at 2-8 °C.
Detection Range
The borderline range of the ELISA antigen Candida test is specified on the quality control certificate and indicates the range for borderline test results. Values obtained, when testing a patient's sample, which fall below this range indicate a negative test result; values above the borderline range are interpreted positive. In cases where the results are within the borderline range a definitive interpretation of the result is not possible. In such cases, the test should be repeated in parallel with a follow-up sample taken one to two weeks later (serum pair).
Detection Limit
The limits of quantification are specified on the quality control certificate of the ELISA antigen test. The linearity of dilution within this range has been demonstrated in comprehensive evaluation studies. In case a patient sample shows a test result above the upper limit of quantification, the sample may be tested at a higher dilution. The thereby determined antigen activity must be multiplied by the additional dilution factor.
The ELISA antigen Candida test was validated by the analysis of 148 serum samples from blood donors and 93 specimens from patients, who showed signs of candidiasis during intensive care treatment, in comparison to the results obtained with a commercially avaliable assay of a leading European manufacturer. Sera classified as borderline were not included in the calculation of sensitivity and specificity values.

In another internal study, cross-reactivity with the species Candida guillermondii, Candida glabrata, Candida krusei, Candida parapsilosis and Candida tropicalis with the ELISA antigen Candida was demonstrated in order to guarantee a comprehensive Candida diagnosis.
Due to a similiarity of mannan with hydroxyethylstarch (HES), which is used in plasma expanders for treatment of circulatory failure (hypovolemic, hemorrhagic and septic shock), potential cross-reactivity was assessed. However, no cross-reaction with HES was measureable when using the ELISA antigen Candida test.
General Description
Candida albicans is an ubiquitous yeast which, like all Candida species, belongs to the family of yeast-like fungi. Apart from the yeast form which primarily causes superficial infections, so called pseudo mycelia are a further morphologic manifestation of yeast-like fungi. Germ tubes and the development of pseudo mycelia mainly occur in cases of systemic mycosis. Candida ssp. produce and excrete a range of destructive enzymes that enable the facultative pathogen microorganisms to penetrate mucous membrane barriers and blood vessels barriers.
Candida ssp. are primarily transmitted by smear contamination from person to person. The primary portal of entry is the oral cavity. Changes in the fungistatic properties of the skin, which are a consequence of a slightly acidic pH value and the antagonistic bacterial flora, can facilitate the establishment of superficial candidiasis of the skin surface. Systemic mycosis results from colonization of mucous membranes, particularly in the gastrointestinal tract.
Candida ssp. are able to adhere to the epithelia of a variety of mucosal membranes by adherence proteins and other cell surface structures. The schematic below shows hypothetical steps that may lead to disseminated infections in cases of severe underlying conditions. An exact description of the various stages is not practical (Fig. 1).

Candidiasis can generally be classified into two major groups whose main characteristics are listed in the table below.

The diagnosis of candidiasis on the basis of serological methods is not straight forward: On the one hand transient yeast colonization may induce an antibody response, on the other hand systemic Candida mycosis in immunosuppressed patients may only lead to minor changes in antibody activities. Such situations make critical interpretation of serological findings necessary. In addition, systemic Candida-infections may not cause typical symptoms.
Currently it is not possible to conclude that the results of different test systems for anti-Candida antibody detection are comparable or even exchangeable. Specificity of detected antibodies significantly depends on the test system (ELISA or HAT) or on the antigen preparation used. The detection of IgM antibodies with HAT is better than the IgG detection due to higher agglutination properties of IgM molecules. HAT mainly detects antibodies against cell wall antigens of yeast-like fungi which makes serological interpretation even more complex but gives the opportunity for differentiation. Changes in antibody concentrations may be detectable with ELISA but not with HAT, making a combination of the two techniques advantageous, e.g. in case of decreasing IgM antibody activity and simultaneously increasing IgG antibody activity.
Currently no single technique in isolation allows for a definitive serological diagnosis of candidiasis. Surveillance of at risk patients and therapy control requires the use of a variety of methods including serology and antigen detection. The Candida albicans antigen ELISA Kit is of particular help in such situations by detecting Candida specific antigen in patient samples.


Have you cited DEIA809 in a publication? Let us know and earn a reward for your research.

Customer Reviews

Write a review, share your experiences with others and get rewarded !
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket
Product Name Cat. No. Applications Host Species Datasheet Price Add to Basket


Zinkeviciene, A; Girkontaite, I; et al. Specific Immunoglobulin E Antibodies to Saprophytic Yeasts in Sera of Atopic Patients Allergic to House Dust Mites. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 22:412-418(2012).
Lasarte, S; Elsner, D; et al. Female sex hormones regulate the Th17 immune response to sperm and Candida albicans. HUMAN REPRODUCTION 28:3283-3291(2013).

Online Inquiry

Phone: *
E-mail Address: *
Technology Interest:
Type of Organization:
Service & Products Interested: *
Project Description:
Verification code
Click image to refresh the verification code.

Online Inquiry

  Interested in larger quantities ? request a quote!
  Protocol may be improved. Please feel free to contact us to obtain the latest version.!

Ordering Information

Payment methods we support:
Invoice / Purchase Order
Credit card

OUR PROMISE TO YOU Guaranteed product quality expert customer support

Inquiry Basket